Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Larimar Therapeutics (LRMR) Cash from Investing Activities: 2013-2020

Historic Cash from Investing Activities for Larimar Therapeutics (LRMR) over the last 7 years, with Dec 2020 value amounting to -$23.5 million.

  • Larimar Therapeutics' Cash from Investing Activities fell 46990.00% to -$23.5 million in Q4 2020 from the same period last year, while for Dec 2020 it was $17.1 million, marking a year-over-year increase of 20.49%. This contributed to the annual value of -$85.4 million for FY2024, which is 356.01% down from last year.
  • As of Q4 2020, Larimar Therapeutics' Cash from Investing Activities stood at -$23.5 million, which was down 294,212.50% from -$8,000 recorded in Q3 2020.
  • Larimar Therapeutics' Cash from Investing Activities' 5-year high stood at $41.4 million during Q2 2020, with a 5-year trough of -$47.4 million in Q3 2018.
  • Moreover, its 3-year median value for Cash from Investing Activities was -$8,000 (2020), whereas its average is $921,818.
  • Within the past 5 years, the most significant YoY rise in Larimar Therapeutics' Cash from Investing Activities was 5,031.07% (2020), while the steepest drop was 46,990.00% (2020).
  • Larimar Therapeutics' Cash from Investing Activities (Quarterly) stood at $16.9 million in 2016, then decreased by 24.97% to $12.7 million in 2017, then rose by 12.43% to $14.3 million in 2018, then crashed by 100.35% to -$50,000 in 2019, then slumped by 46,990.00% to -$23.5 million in 2020.
  • Its Cash from Investing Activities stands at -$23.5 million for Q4 2020, versus -$8,000 for Q3 2020 and $41.4 million for Q2 2020.